Home » Stocks » PPD

PPD, Inc. (PPD)

Stock Price: $32.88 USD -0.27 (-0.81%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 11.49B
Revenue (ttm) 4.36B
Net Income (ttm) 53.83M
Shares Out 349.57M
EPS (ttm) 0.16
PE Ratio 205.50
Forward PE 24.63
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $32.88
Previous Close $33.15
Change ($) -0.27
Change (%) -0.81%
Day's Open 33.15
Day's Range 32.12 - 33.34
Day's Volume 1,690,518
52-Week Range 10.61 - 37.51

More Stats

Market Cap 11.49B
Enterprise Value 15.14B
Earnings Date (est) Mar 10, 2021
Ex-Dividend Date n/a
Shares Outstanding 349.57M
Float 113.94M
EPS (basic) 0.16
EPS (diluted) 0.16
FCF / Share 0.67
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.49%
FCF Yield 2.04%
Payout Ratio n/a
Shares Short 1.82M
Short Ratio 0.40
Short % of Float 1.60%
Beta n/a
PE Ratio 205.50
Forward PE 24.63
P/FCF Ratio 48.96
PS Ratio 2.63
PB Ratio n/a
Revenue 4.36B
Operating Income 454.71M
Net Income 53.83M
Free Cash Flow 234.74M
Net Cash -3.65B
Net Cash / Share -10.44
Gross Margin 61.31%
Operating Margin 10.42%
Profit Margin 1.20%
FCF Margin 5.38%
ROA 4.74%
ROE n/a
ROIC 6.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (17)

Buy 15
Overweight 1
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(21.44% upside)
Current: $32.88
Target: 39.93
*Average 12-month price target from 15 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth7.52%24.92%12%-
Gross Profit1,6221,4741,4641,293
Operating Income417373218286
Net Income47.82104296183
Shares Outstanding279279291312
Earnings Per Share0.190.340.680.58
EPS Growth-44.12%-50%17.24%-
Operating Cash Flow433423359408
Capital Expenditures-126-116-105-90.22
Free Cash Flow307307254318
Cash & Equivalents345553419-
Total Debt5,8444,7964,822-
Net Cash / Debt-5,498-4,243-4,403-
Book Value-2,698-1,522-1,492-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PPD, Inc.
Country United States
Employees 24,000
CEO David S. Simmons

Stock Information

Ticker Symbol PPD
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: PPD
IPO Date February 6, 2020


PPD provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.